Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Current Leases (2019 - 2025)

X4 Pharmaceuticals' Current Leases history spans 7 years, with the latest figure at $994000.0 for Q4 2025.

  • For Q4 2025, Current Leases fell 20.54% year-over-year to $994000.0; the TTM value through Dec 2025 reached $994000.0, down 20.54%, while the annual FY2025 figure was $994000.0, 20.54% down from the prior year.
  • Current Leases reached $994000.0 in Q4 2025 per XFOR's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $1.4 million in Q2 2025 to a low of $875000.0 in Q1 2021.
  • Average Current Leases over 5 years is $1.1 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Current Leases: soared 37.7% in 2021, then decreased 20.54% in 2025.
  • A 5-year view of Current Leases shows it stood at $1.1 million in 2021, then increased by 11.44% to $1.2 million in 2022, then dropped by 8.26% to $1.1 million in 2023, then rose by 13.83% to $1.3 million in 2024, then dropped by 20.54% to $994000.0 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Current Leases are $994000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.4 million (Q2 2025).